TWICE UPON A TIME Trademark

Trademark Overview


On Wednesday, December 13, 2023, a trademark application was filed for TWICE UPON A TIME with the United States Patent and Trademark Office. The USPTO has given the TWICE UPON A TIME trademark a serial number of 98312385. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 20, 2024. This trademark is owned by Revance Therapeutics, Inc.. The TWICE UPON A TIME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; dermatological pharmaceutical preparations injected into or under the skin, and into or under mucous membranes, the foregoing for filling in wrinkles, filling in skin depressions for remodeling the surface of the skin, increasing volume in the face or any other part of the body, for moisturizing the skin or mucous membranes, and for increasing...
twice upon a time

General Information


Serial Number98312385
Word MarkTWICE UPON A TIME
Filing DateWednesday, December 13, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; dermatological pharmaceutical preparations injected into or under the skin, and into or under mucous membranes, the foregoing for filling in wrinkles, filling in skin depressions for remodeling the surface of the skin, increasing volume in the face or any other part of the body, for moisturizing the skin or mucous membranes, and for increasing lip volume

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Wednesday, December 13, 2023NEW APPLICATION ENTERED
Sunday, March 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2024ASSIGNED TO EXAMINER
Monday, June 17, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2024NON-FINAL ACTION WRITTEN
Monday, June 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED